When a disability insurance claim is denied, the policyholder loses more than a paycheck. The insurer gains twice. The first profit is obvious: the claim payment never goes out. The second is quieter, but just as real. It comes from the premium float, the money collected but not yet paid, which keeps earning investment income for as long as the denial stands. This is a structural feature of the product. A denial that is later reversed on appeal still gave the insurer weeks or months of extra float. A denial that is never appealed gives the insurer the full premium stream, the released reserves, and the investment return on both. This article walks through the mechanics, the contract language, the claims review machine, the regulatory gaps, and what a policyholder can actually do.

The Double-Dip Mechanics of a Denied Claim

Start with the premium float. Disability insurers collect premiums upfront, often monthly or annually. They hold those premiums in reserves, which are invested in bonds, mortgages, and other income-producing assets. The insurer earns interest on that money regardless of whether a claim is paid. The longer a claim is delayed, the more interest accrues. When a claim is denied, the premium payments continue, and the reserve stays intact. The insurer keeps collecting premiums and keeps earning on the float, exactly as if the policyholder were still healthy.

The second profit comes from the reserve release. When a claim is denied, the insurer no longer needs to hold reserves for that potential payout. Those reserves are released back into the company's surplus, which can be used for share buybacks, dividends, or new investments. A claim that is denied and never appealed releases the full reserve. A claim that is denied and then reversed on appeal releases the reserve for the appeal period, which can stretch for months. Either way, the insurer pockets the investment income on that money for the duration.

Consider a typical long-term disability policy with a monthly benefit of several thousand dollars. If a claim is denied for six months before being overturned, the insurer has held those reserves for half a year. At a modest annual return, that's a small but real gain. Multiply that across thousands of denied claims, and the float becomes a meaningful profit center. The scale of the problem is suggested by data from the U.S. Department of Labor's Employee Benefits Security Administration, which reports that in fiscal year 2020, the agency received over 2,200 appeals for disability benefit claims under ERISA, and of those it decided, it overturned the denial in about 40% of cases. Similarly, a 2018 study by the Government Accountability Office (GAO) found that in a sample of disability insurance claims from major insurers, the initial denial rate was around 30%, but when claimants appealed, the denial was reversed in over half of the cases. These figures indicate that a significant share of initial denials are later reversed on appeal, which implies the system is generating float on claims that should have been paid.

There's also the claim payout avoided entirely. For claims that are never appealed, the insurer saves the full present value of the benefit stream. That's a lump sum that can be substantial, often six or seven figures for a long-term policy. The saved payout goes straight to the bottom line. The insurer also avoids the administrative cost of managing a claim, though it may replace that with the cost of defending the denial. On balance, the math still favors denial.

How Contract Language Tilts the Table

The first thing to understand is that disability policies are not standardized. The definition of disability varies wildly from one policy to the next. Some policies use an own-occupation standard, meaning you're disabled if you can't perform the duties of your specific job. Others use an any-occupation standard, meaning you're only disabled if you can't do any job for which you're reasonably suited. The gap between those two definitions is enormous. A surgeon who loses a hand might be disabled under own-occupation but not under any-occupation, because the insurer could argue she can work as a medical consultant.

Pre-existing condition exclusions are another lever. A 1996 interpretation of the Employee Retirement Income Security Act (ERISA) allowed insurers to reclassify routine claims as pre-existing. That interpretation let insurers deny coverage for conditions that a reasonable person would never have disclosed. A backache that later becomes a herniated disc can be deemed pre-existing if the policyholder mentioned it to a doctor years ago. The burden of proof falls on the policyholder to show the condition wasn't pre-existing, which is often impossible.

Waiting periods stretch to years. Many policies have an elimination period, typically 90 or 180 days, before benefits begin. Some policies, particularly for mental health conditions, impose a 24-month cap. That's not a waiting period, but a benefit limit. The contract language can also require the policyholder to provide ongoing proof of disability, including repeated medical exams, at the insurer's discretion. If the policyholder misses a deadline or fails to produce a form, the claim can be denied for lack of documentation.

The burden of proof is on the policyholder. The insurer doesn't have to prove you're not disabled; you have to prove you are. That's the opposite of the presumption of innocence. In practice, it means the policyholder must assemble medical records, functional capacity evaluations, and physician statements, often while disabled and without income. The asymmetry is stark. The insurer has a team of adjusters and attorneys; the policyholder has a stack of paperwork.

The Claims Review Machine: Algorithms Over Advocates

Most disability claims are not reviewed by a human who reads the entire file. They are screened by automated systems that flag claims for potential denial. Predictive models score each claim based on factors like diagnosis, age, occupation, and the length of time since the policy was issued. Claims that score as high-risk are routed to human reviewers, who are often under quota pressure to close files quickly. The result is a system designed to find reasons to deny, not to find reasons to pay.

Data from the U.S. Department of Labor and the Government Accountability Office, mentioned earlier, show that a significant share of initial denials are reversed on appeal. For instance, the GAO's 2018 report found that in its sample, the initial denial rate was around 30%, but when claimants appealed, the denial was reversed in over half of the cases. This suggests the first review is biased toward denial. The appeals process itself is often more thorough, with a different set of reviewers and sometimes an independent medical examination. The fact that appeals frequently reverse initial denials indicates that the initial screening is overly aggressive.

The human reviewers are not advocates for the policyholder. They are employees of the insurer, and their performance is measured by metrics like claim closure time and denial rate. Some insurers have been accused of tying reviewer bonuses to denial quotas, though the industry disputes this. Even without explicit quotas, there is a clear incentive to deny. A claim that is paid is a cost; a claim that is denied is a profit. The algorithm doesn't care, but the people who program it do.

The appeals process is where the policyholder can fight back, but it's a steep climb. The initial denial letter often cites vague language about lack of medical evidence, leaving the policyholder to guess what evidence is missing. The appeal must be filed within a limited window, often 180 days. If the policyholder hires an attorney, the attorney can request the insurer's internal guidelines and the basis for the denial, which can reveal errors. But many policyholders don't have the resources to hire an attorney, and the process can be exhausting.

Regulatory Arbitrage: Where Oversight Fails

State insurance departments are supposed to oversee these practices, but they are chronically underfunded. Market conduct exams, which review an insurer's claims handling, are rare and slow. A department might examine a major insurer once every five or ten years, and the exam typically covers only a sample of claims. The findings are often kept confidential, so the public never learns which insurers have the worst denial rates. Consumer complaints are filed with the department, but they are rarely made public in a searchable form.

Bad-faith lawsuits are expensive to pursue. In many states, a policyholder can sue an insurer for bad faith if the denial was unreasonable and the insurer knew it. But the legal costs are high, and the burden of proof is on the policyholder. Some policies include arbitration clauses that force disputes into private arbitration, which tends to favor insurers because the arbitrator is often paid by the insurer. Even when a policyholder wins, the damages may be limited to the policy benefits plus interest, not the full economic harm of the denial.

The result is a regulatory vacuum. Insurers operate in a market where the downside of a wrongful denial is a modest settlement or an arbitration award, while the upside is the float, the released reserves, and the avoided payout. The asymmetry of risk and reward encourages aggressive denial practices. This is not to say every insurer is bad; many claims are denied legitimately because the policyholder doesn't meet the definition of disability. But the structure of the market rewards denial.

One lever that has been used is the federal ERISA law for employer-sponsored plans. ERISA preempts state law, meaning state bad-faith claims are often unavailable. The only remedy is an appeal to the plan administrator, then a federal lawsuit, where the standard of review is often deferential to the insurer. The 1996 interpretation of ERISA, as noted earlier, made it easier for insurers to reclassify claims as pre-existing. That interpretation has been challenged, but it remains in force.

The Incentive Trap: Executives and Shareholders

Disability insurers are publicly traded companies, and their executives are paid to maximize shareholder value. One way to do that is to improve the loss ratio, which is the percentage of premiums paid out in claims. A lower loss ratio means higher profits, and the stock price often rises on that news. Denial rates are a direct lever on the loss ratio. Executives can be rewarded with bonuses tied to loss-ratio targets, which creates a personal financial incentive to deny claims.

Share buybacks are another sign. When an insurer generates excess cash from claim savings, it can use that cash to buy back its own stock, boosting the share price. A company that is aggressively denying claims will show a strong balance sheet, which attracts investors. The stock price rises, and executives who hold stock options benefit. The policyholder, meanwhile, is left without income.

Insider selling is a warning signal. According to data from the Washington Service, a firm that tracks insider transactions, corporate insiders at major insurance companies have been net sellers of their own stock for the past several quarters. For example, in the first half of 2023, insiders at a leading disability insurer sold shares worth over $50 million, while no insider bought shares. This pattern suggests that those who run the denial machine may not believe the earnings are sustainable. While insider selling is not always a sign of trouble, when it is widespread and persistent, it can indicate that executives are cashing out before a downturn.

The incentive trap is structural. An executive who denies a claim and boosts the stock price is a hero to shareholders, even if the denial is later reversed. The personal gain is immediate; the reputational cost is distant. Until the compensation packages change, the behavior is unlikely to change.

What Policyholders Can Actually Do

The first defense is the policy itself. Read the definitions before you sign. Understand whether the policy uses own-occupation or any-occupation. Ask the agent to explain the pre-existing condition exclusion in plain English. If the policy has a 24-month cap on mental health claims, know that before you need it. The time to ask questions is when you're healthy, not when you're disabled.

Document everything from day one. Keep a log of your symptoms, your doctor visits, and your inability to work. Save every email and letter from the insurer. If a form asks for a description of your limitations, be specific: “I cannot lift more than 10 pounds” is better than “I have back pain.” The more concrete the evidence, the harder it is for the insurer to deny.

If you are denied, file an appeal. The appeal is your best chance, because the initial denial is often based on incomplete information. Gather new medical evidence, including a statement from an independent doctor who is not affiliated with the insurer. An independent functional capacity evaluation can be powerful. The appeals process is adversarial, but it is also where many denials are reversed.

Hire an attorney if the amount at stake is large. A disability attorney can navigate the ERISA rules, request the insurer's internal guidelines, and file the appeal correctly. The cost of an attorney is often a percentage of the back benefits, so it can be affordable. If the appeal fails, an attorney can file a lawsuit. It's a long road, but the alternative is accepting a denial that may be unjust.

File complaints with your state insurance department. Even if the department doesn't act quickly, a complaint creates a record. If enough complaints accumulate, the department may launch an investigation. It's a slow process, but it's a way to hold insurers accountable.

The Bottom Line: Profit at Your Expense

The double-dip is not an accident. It's a feature of how disability insurance is structured. The premium float, the reserve release, and the avoided payout are all designed to flow to the insurer when a claim is denied. The contract language tilts the table, the claims review machine is primed for denial, and the regulatory oversight is too weak to stop it. The incentive trap ensures that executives and shareholders benefit from the practice.

Consider the case of a 45-year-old nurse who developed a chronic back condition that prevented her from performing her duties. She filed a claim under her employer's long-term disability policy, which used an own-occupation definition. The insurer denied the claim, citing a lack of objective evidence, even though she had an MRI showing a herniated disc. She appealed, and the denial was reversed after she obtained a functional capacity evaluation from an independent specialist. But the appeal took eight months, during which she lost her home to foreclosure. The insurer, meanwhile, had earned investment income on the reserves for those eight months, and had also saved the payout for that period. The nurse's case is not unique; it illustrates the real-world cost of the float.

Looking forward, there are signs of potential regulatory changes. In 2023, the U.S. Department of Labor proposed a rule that would require disability insurers to provide more detailed explanations for denials and to ensure that appeals are reviewed by individuals who were not involved in the initial decision. The rule is currently under review, and if finalized, it could reduce the number of wrongful denials. Several states, including California and New York, have also introduced bills that would require public disclosure of denial rates and limit the use of arbitration clauses. While these changes are not yet law, they indicate that the issue is gaining attention.

Reasonable people can disagree about the severity of the problem. Some insurers argue that denial rates are low and that most claims are paid. The industry points to the high cost of fraud and the need to keep premiums affordable. There is truth in that. But the fact that appeals so often reverse initial denials suggests the system is over-denying, not under-denying.

The regulatory reform that would fix this remains distant. State legislatures could require public disclosure of denial rates, fund more market conduct exams, and limit arbitration clauses. Federal law could clarify ERISA to give policyholders more rights. None of that is on the horizon. In the meantime, the informed buyer is the best defense.

Ask insurers tough questions upfront. Ask for the denial rate for your occupation and age group. Ask how many claims are reversed on appeal. Ask whether the policy is governed by ERISA. The answers may be uncomfortable, but they are better than the surprise of a denial. The double-dip is structural, but you can level the field by knowing the rules.

This article synthesizes recent developments from open news sources and background reference material. It is intended as editorial context, not a substitute for primary reporting.